医学
二尖瓣夹子
透视
烧蚀
导管消融
心脏病学
导管
内科学
心室
射血分数
二尖瓣反流
冠状窦
经皮
室性心动过速
外科
心力衰竭
作者
Laurent Haegeli,Giuseppe D’Angelo,Nicola Trevisi,Stefano Stella,Alexander Berndt,Fırat Duru,Corinna Brunckhorst,Paolo Della Bella
摘要
VT Ablation in MitraClip Patients Introduction Patients with mitral regurgitation are increasingly treated by percutaneous implantation of a MitraClip device (Abbott Park, IL, USA). We investigate the feasibility and safety of the transmitral catheter route for catheter ablation of ventricular tachycardia (VT) in these patients. Methods The mitral valve with the MitraClip in situ was crossed under transesophageal 3‐dimensional echocardiographic and fluoroscopic guidance using a steerable sheath for ablation of the left ventricle. Results Five patients (all males, median age 74.0 ± 16.0 years) who had previously a MitraClip implanted were referred for catheter ablation of VT. The left ventricular ejection fraction was 29.0% ± 24.0%. One patient had both an atrial septal defect and a left atrial appendage occluder device in addition to a MitraClip. The duration between MitraClip implantation and ablation was 1019.0 ± 783.0 days. After transseptal puncture, ablation catheter was successfully steered through the mitral valve with the use of fluoroscopy. A complete high‐density map of the substrate in sinus rhythm could be obtained in all patients using multipolar mapping catheters. In 1 patient, mapping was carried out using a mini‐basket catheter. Procedural endpoints, noninducibility of all VTs, and abolition of all late potentials were achieved in all patients. Procedure time was 255.0 ± 52.5 minute, fluoroscopy time was 23.0 ± 7.3, and the radiation dose was 61.0 ± 37.5 Gycm 2 . No mitral insufficiency or worsening of regurgitation was documented after the procedure. Conclusions This is the first report demonstrating the feasibility and safety of VT ablation in patients with a MitraClip device using the anterograde transmitral catheter route.
科研通智能强力驱动
Strongly Powered by AbleSci AI